Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SNDX is expected to report earnings to rise 12.73% to -124 cents per share on May 12

Syndax Pharmaceuticals SNDX Stock Earnings Reports

Q1'25

Est.

$-1.24

Q4'24

Missed

by $0.26

Q3'24

Beat

by $0.09

Q2'24

Beat

by $0.11

Q1'24

Beat

by $0.14

The last earnings report on March 03 showed earnings per share of -110 cents, missing the estimate of -83 cents. With 1.34M shares outstanding, the current market capitalization sits at 1.11B.

View a ticker or compare two or three

Compare

SNDX